PCOS ICD-10 Code E28.2: What It Covers and Why Your Claim Was Denied

What does the PCOS ICD-10 code E28.2 actually cover?

E28.2, labelled “Polycystic ovarian syndrome,” is the single ICD-10-CM code used for every Rotterdam phenotype and both classic and lean presentations of the condition. It sits inside category E28, Ovarian dysfunction, alongside four related codes that get confused with it more often than you’d expect.

One code covering all four Rotterdam phenotypes is also its biggest limitation: E28.2 alone cannot tell an insurer, a specialist, or your own future self which two of the three criteria were met, or how severe the picture was. That detail lives in the chart note, not the code — whether that note points to an ultrasound finding or a diagnosis reached without one.

Why was my claim denied under E28.2?

Claims tied to E28.2 are denied for documentation reasons far more often than for a coding error in the code itself. A 2025 systematic review of studies validating PCOS identification in administrative health data found that ICD-based case definitions matched a confirmed diagnosis with a pooled positive predictive value of 88% (95% CI 82–95%) across the reviewed studies — individual studies ranged from 30% to 96% depending on how strictly the code was applied. That gap — a meaningful share of E28.2 entries not matching confirmed Rotterdam-criteria documentation in the underlying chart — is the same gap a payer’s medical-necessity review is looking for when it questions a claim.

Is there a separate ICD-10 code for PMOS?

No distinct ICD-10-CM code for PMOS exists as of this writing. E28.2 remains the correct code to use, because the 2026 rename to polyendocrine metabolic ovarian syndrome came from a medical-society consensus process, not from the World Health Organization or the US coding bodies that actually govern ICD-10-CM.

The full story of why the name changed at all is covered here. Those are separate processes on separate timelines. A clinical naming consensus can be agreed and published in a matter of months; a coding-system change goes through the WHO for the international classification, and through CMS and the National Center for Health Statistics for the US clinical-modification version, which updates on an annual cycle. When a condition’s name changes without its underlying diagnostic criteria changing — which is explicitly the case here, since the 2023 guideline’s criteria are unchanged by the rename — coding bodies have typically relabelled the existing code rather than issued a new one. Whether that happens here, and when, has not been announced. Until it is, expect E28.2 on your chart and your claims regardless of which name your clinician uses in conversation.

What this code signals beyond a single visit

E28.2 in your record is not just a billing formality — it is the entry that lets a future provider, or your own record years from now, confirm the diagnosis without repeating the whole work-up. That continuity matters because the alternative is common: in an observational survey of 1,385 women with a reported PCOS diagnosis, 33.6% said it took more than two years and 47.1% saw three or more health professionals before the diagnosis was actually made — the full breakdown of that delay is here. A missing or inconsistent code is one of the ordinary reasons that history has to be re-established at each new appointment.

The condition behind that code also carries a measurable cost. A 2022 analysis estimated the health-care-related economic burden of PCOS in the United States, across pregnancy-related and long-term consequences, at roughly $8 billion a year in 2020 dollars — the kind of figure that is part of why accurate coding, not just accurate treatment, gets scrutinised by payers in the first place.

What E28.2 does not do

• It does not guarantee coverage. Some plans exclude entire treatment categories, such as infertility care, regardless of how correctly the diagnosis is coded. Correct coding is necessary for a fair claims decision; it is not sufficient against a structural exclusion.
• It does not capture severity or phenotype. Two people with very different presentations — one with regular cycles and mild hirsutism, one with amenorrhoea and marked insulin resistance — share the identical code. A prior authorisation that depends on severity, such as for a GLP-1 prescription, needs additional documentation beyond E28.2 alone.
• It does not become “PMOS” automatically. Expect both names in circulation in your own records for some time yet.
• It is not perfectly reliable at the population level. With individual-study accuracy for ICD-based PCOS identification ranging from 30% to 96%, research and public-health statistics drawn purely from claims data undercount or overcount real prevalence depending on the dataset — worth knowing if you are ever told a database “doesn’t show” a diagnosis you know is real and documented elsewhere in your chart.

Your next step

If you have ever had a PCOS-related claim questioned or denied, request the visit note tied to that claim and check three things: whether E28.2 or E28.9 was actually submitted, whether the note names which two criteria were met, and whether the denial is a documentation issue or a plan-level exclusion. Those are three different problems with three different fixes, and knowing which one you have is most of the way to resolving it. The work-up itself, from the first appointment through to the record you end up carrying forward, is covered in full separately.